ARTICLE | Company News
Arachos Pharma inflammation news
September 2, 2013 7:00 AM UTC
Arachos received a £1.2 million ($1.9 million) award from the U.K. Biomedical Catalyst fund to develop AP362 to treat inflammatory diseases. AP362 is an oral selective glucocorticoid receptor (GCCR)...